168 related articles for article (PubMed ID: 15379837)
1. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study.
Card TR; West J; Holmes GK
Aliment Pharmacol Ther; 2004 Oct; 20(7):769-75. PubMed ID: 15379837
[TBL] [Abstract][Full Text] [Related]
2. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study.
Grainge MJ; West J; Solaymani-Dodaran M; Card TR; Logan RF
Aliment Pharmacol Ther; 2012 Mar; 35(6):730-9. PubMed ID: 22288441
[TBL] [Abstract][Full Text] [Related]
3. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
4. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study.
Viljamaa M; Kaukinen K; Pukkala E; Hervonen K; Reunala T; Collin P
Dig Liver Dis; 2006 Jun; 38(6):374-80. PubMed ID: 16627018
[TBL] [Abstract][Full Text] [Related]
5. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
6. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
[TBL] [Abstract][Full Text] [Related]
9. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.
Smedby KE; Akerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J
Gut; 2005 Jan; 54(1):54-9. PubMed ID: 15591504
[TBL] [Abstract][Full Text] [Related]
10. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
Geier D; Hebert B; Potti A
Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
[TBL] [Abstract][Full Text] [Related]
11. Incidence of cancer among patients with atopic dermatitis.
Hagströmer L; Ye W; Nyrén O; Emtestam L
Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
[TBL] [Abstract][Full Text] [Related]
12. Cancer following cardiac catheterization in childhood.
Modan B; Keinan L; Blumstein T; Sadetzki S
Int J Epidemiol; 2000 Jun; 29(3):424-8. PubMed ID: 10869313
[TBL] [Abstract][Full Text] [Related]
13. Risk of lymphoma in inflammatory bowel disease.
Loftus EV; Tremaine WJ; Habermann TM; Harmsen WS; Zinsmeister AR; Sandborn WJ
Am J Gastroenterol; 2000 Sep; 95(9):2308-12. PubMed ID: 11007233
[TBL] [Abstract][Full Text] [Related]
14. Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study.
Lohi S; Mäki M; Montonen J; Knekt P; Pukkala E; Reunanen A; Kaukinen K
Gut; 2009 May; 58(5):643-7. PubMed ID: 18852259
[TBL] [Abstract][Full Text] [Related]
15. [Cancer risk in coeliac disease].
Brottveit M; Lundin KE
Tidsskr Nor Laegeforen; 2008 Oct; 128(20):2312-5. PubMed ID: 19096486
[TBL] [Abstract][Full Text] [Related]
16. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
17. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignant neoplasms after liver transplantation: a population-based study.
Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
[TBL] [Abstract][Full Text] [Related]
19. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
20. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
